Study opens new prospects for developing new targeted therapies for breast cancer
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer ...
Cancer
May 02, 2013 |
5 / 5 (1) |
0
Genetic markers linked to the development of lymphedema in breast cancer survivors
A new UCSF study has found a clear association between certain genes and the development of lymphedema, a painful and chronic condition that often occurs after breast cancer surgery and some other cancer treatments.
Cancer
Apr 16, 2013 |
5 / 5 (1) |
0
|
DNA test shows promise in guiding advanced breast cancer care
(HealthDay)—An experimental blood test could help show whether women with advanced breast cancer are responding to treatment, a preliminary study suggests.
Cancer
Mar 13, 2013 |
5 / 5 (1) |
0
|
Study finds small increase in incidence of advanced breast cancer among younger women
An analysis of breast cancer trends in the U.S. finds a small but statistically significant increase in the incidence of advanced breast cancer for women 25 to 39 years of age, without a corresponding increase in older women, ...
Cancer
Feb 26, 2013 |
not rated yet |
0
Medical marijuana: Voodoo or legitimate therapeutic choice?
(HealthDay)—Imagine a 68-year-old woman with advanced breast cancer, looking for a better way to ease her chronic pain, low appetite, fatigue and nausea. Should she or shouldn't she be prescribed marijuana?
Medications
Feb 21, 2013 |
3 / 5 (6) |
12
PET/CT shows clear advantages over conventional staging for breast cancer patients
New research published in the January issue of The Journal of Nuclear Medicine shows that 18F-fludeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging offers significant prognostic strati ...
Cancer
Jan 02, 2013 |
not rated yet |
0
American Society of Clinical Oncology issues annual report on state of clinical cancer science
The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major ...
Cancer
Dec 03, 2012 |
not rated yet |
0
Delaying treatment for advanced breast cancer more than 60 days has 'profound effect', researchers find
(Medical Xpress)—Results from a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) show ...
Cancer
Nov 22, 2012 |
5 / 5 (1) |
0
|
Awareness could eliminate inequalities in cancer diagnoses
There are substantial inequalities in the stage at which cancer patients receive their diagnosis – a critical factor for cancer survival – a new study by the University of Cambridge reveals. The researchers found that ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy
The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological ...
Cancer
Nov 01, 2012 |
5 / 5 (1) |
0
Prostate cancer: Curcumin curbs metastases
Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universität ...
Cancer
Oct 12, 2012 |
5 / 5 (2) |
0
|
New drug approved for lack of certain white blood cells
(HealthDay)—The U.S. Food and Drug Administration has approved the drug tbo-filgrastim to treat certain cancer patients undergoing chemotherapy who have a condition called severe neutropenia, the FDA said in a news release.
Medications
Aug 30, 2012 |
not rated yet |
0
Research identifies a promising new therapeutic target for aggressive breast cancer
Scientists at Western University have identified a new therapeutic target for advanced breast cancer which has shown tremendous promise in mouse models. The study led by Lynne-Marie Postovit of Western's Schulich School of ...
Cancer
Aug 01, 2012 |
not rated yet |
0
|
Afinitor approved for advanced breast cancer
(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food ...
Medications
Jul 23, 2012 |
not rated yet |
0
Scientists decode DNA to find breast tumor signatures that predict treatment response
Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering ...
Genetics
Jun 10, 2012 |
4.8 / 5 (4) |
0
|
